Hepion Pharmaceuticals In... (HEPA)
NASDAQ: HEPA
· Real-Time Price · USD
0.07
0.01 (22.59%)
At close: Jun 09, 2025, 3:45 PM
Hepion Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -13.19M | -22.7M | -28.37M | -38.52M | -48.93M | -44.68M | -42.7M | -48.53M | -42.2M | -45.12M | -45.84M | -33.6M | -32.73M | -27.96M | -24.92M | -22.19M |
Depreciation & Amortization | 30.76K | 43.02K | 61.52K | 79.85K | 67.13K | 73.34K | 72.57K | 72.77K | 77.46K | 82.4K | 87.78K | 90.66K | 86.07K | 76.24K | 60.34K | 46.13K |
Stock-Based Compensation | 791.64K | 913.34K | 1.2M | 115.33K | 1.34M | 1.42M | 1.72M | 2.94M | 2.55M | 3.17M | 4.02M | 5.25M | 4.67M | 4.81M | 4.33M | 3.33M |
Other Working Capital | 1.61M | 754.69K | -1.01M | 547.99K | 2.67M | 4.93M | 5.64M | 7.9M | 983.34K | 111.89K | -4.34M | -8.55M | -4.5M | -5.08M | -1.81M | -390.09K |
Other Non-Cash Items | 101.16K | -480.46K | -1.03M | 3.41M | -440K | -260K | -40K | -41.57K | -414.99K | 395.92K | 1.07M | 1.97M | 2.32M | 1.58M | 846.86K | 136.37K |
Deferred Income Tax | n/a | 4.1M | 4.1M | 4.1M | 4.1M | n/a | n/a | 1.87M | 1.87M | 1.88M | 1.88M | 10.91K | 10.91K | -19.16K | -53.15K | -3.63K |
Change in Working Capital | -2.68M | -4.67M | -7.49M | -2.21M | 2.97M | 6.76M | 2.96M | 10.64M | 3.15M | 2.06M | 2.46M | -7.71M | -5.57M | -6.88M | -1.21M | -157.14K |
Operating Cash Flow | -18.22M | -26.07M | -34.78M | -36.29M | -40.89M | -36.68M | -37.98M | -33.05M | -34.96M | -37.55M | -36.33M | -34M | -31.22M | -28.37M | -20.89M | -18.84M |
Capital Expenditures | n/a | -348 | 2.23K | -14.3K | -14.3K | -30.29K | -32.87K | -16.34K | -16.34K | n/a | -36.49K | -48.3K | -130.41K | -206.95K | -170.47K | -170.09K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.27K | 2.27K | 2.27K | 2.27K | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -600K | -600K | n/a | n/a | n/a | n/a | n/a | 2.27 | 2.27 | 2.27 | 2.27 | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -600K | -600.35K | 2.23K | -14.3K | -14.3K | -30.29K | -32.87K | -14.07K | -14.07K | 2.27K | -34.22K | -48.3K | -130.41K | -206.95K | -170.47K | -170.09K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 176.59K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | -1K | -1K | -1K | -1K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 4.35M | 8.84M | 6.34M | 6.34M | 4.49M | -3.14M | -3.14M | -3.14M | -5.14M | -2M | -2M | -2.18M | -176.59K | -176.59K | -176.59K | 4.46M |
Financial Cash Flow | 4.35M | 8.84M | 6.34M | 6.34M | 4.49M | -3.14M | -3.14M | -3.14M | -5.14M | -2M | -2M | -2.18M | 81.98M | 113.59M | 113.59M | 118.41M |
Net Cash Flow | -14.38M | -17.79M | -28.41M | -29.89M | -36.4M | -39.86M | -41.19M | -36.23M | -40.16M | -39.59M | -38.38M | -36.23M | 50.62M | 85.02M | 92.53M | 99.4M |
Free Cash Flow | -18.22M | -26.07M | -34.78M | -36.31M | -40.9M | -36.71M | -38.02M | -33.06M | -34.98M | -37.55M | -36.37M | -34.05M | -31.35M | -28.57M | -21.07M | -19.01M |